|
1
|
- Bernard Cohen, M.D.
- Director of Pediatric Dermatology
- Johns Hopkins Children’s Center
- Dermatlas.org
|
|
2
|
|
|
3
|
- Social stigma
- Anxiety, paranoia
- Families spend $160,000,000/year
- Products range from $10-28/person/rx
- Most recommend 2 rx/person
|
|
4
|
- Lice in existence for several million years
- Documented in writing for sevaral thousand
- 560 species of blood sucking lice-only in mammals
- Insects in order Anoplura, only 2 genera infest humans: Pthirus, Pediculus
- 3 species in humans: P. humanus
capitis, P. humanus humanus, Pthirus pubis
|
|
5
|
- Exodus 8:17 Aaron”stretched out his hand with his rod and smote the dust
of the earth, and it became lice in men and beast.”
- Identified in Egyptian, N American Indian mummies
- Aztecs offered to gods
- Young women in Siberia threw at men as sign of affection
- Tonga-catching and eating of parents lice sign of respect
- Medieval Swedes used lice to select mayor
|
|
6
|
|
|
7
|
|
|
8
|
|
|
9
|
|
|
10
|
|
|
11
|
|
|
12
|
- Endemic in US, incidence ? Rising
- No area free-prevalence in schools <1%-40%
- All races x Afro-Americans, Africans not spared (adaptations of claws or
egg laying anatomy in African organism?)
- Risk factors-brown, red hair; female?; length not factor
- Girls>boys>women>men
- Not vector for any serious infection (unlike body lice)
|
|
13
|
- No Good studies of safety or efficacy
- Rx agents limited
- Variable ovicidal activity
- Treatment failures
|
|
14
|
- Numcuoglu KY, Hemingway J, Miller J, et al. Permethrin resistance in the head
louse Pediculus capitis from Israel.
Med Vet Entomol 1995;9:427-32
- Burgess IF, Peock S, Brown CM, et al.
Head lice resistant to pyrethroid insecticides in Britain. Br Med J 1995;311:752(letter)
|
|
15
|
- Downs AM, Stafford KA, Harvey I, Coles GL. Evidence for double resistance to
permethrin and malathion in head lice.
Br J Dermatol 1999;141:508-11.
- Meinking TL et al. Are head lice
becoming selective in their resistance.
Arch Dermatol 2002;138:220-8.
|
|
16
|
- Genetic mutations in human lice
- At least 2 different pathways
- Hemingway J, et al. Pyrethroid
resistance mechanisms in the head louse P. capitis from Israel. Med Vet Entomol 1999;13:89-96.
- Lee SH, et al. Molecular analysis
of Kdr-like resistance in permethrin resistant strains of head lice P.
capitis. Pest Biochem Physiol 2000;66:130-43.
|
|
17
|
|
|
18
|
- Learned how to collect critters
- Bioassay for crawlers (knock down time)
- Technique for studying nits
- Infrastructure for accessing students
- Decreased sensitivity to various components of pediculicide
- Body louse model not adequate
- Further study necessary
|
|
19
|
|
|
20
|
- Permethrin 1% cream rinse (Nix)
- Few studies
- Residual effect
- Resistance
- Chrysanthemum allergy
- Pyrethrum with piperonyl butoxide
(RID, A200) shampoo
- Few Studies
- No residue
- Resistance
- Ragweed allergy
|
|
21
|
|
|
22
|
|
|
23
|
- • Lindane 1% shampoo
- Poor ovicidal activity
- Safety issues in children
- Resistance
- • Malathion 0.5% lotion (Ovide)
- High ovicidal activity
- Poor cosmetic acceptability
- Flammable
- Residual effect
|
|
24
|
- Q 3-4 day Nix 12-16 days
- Permethrin 5% cream
- Carbaryl 0.5%
- Petrolatum, hair gel
- Trimethoprim/sulfa
- Ivermectin
- Professional nit pickers
|
|
25
|
- Compounds that interfere with glue
- Compounds that repel female mites from laying eggs on hair shaft
- Agents that coat hair shaft and restrict oxygen transfer (Burkhard
CN. J Am Acad Dermatol
2005;53:129-33)
|
|
26
|
|
|
27
|
- Transmission at home
- No nit policy disruptive
- Home grooming and exams
- Second treatment
- Ovide best ovicidal but
- expensive, inflammatory
|
|
28
|
- Failure of effective agents
- Viable residual nits
- Reexposure (Elston, Cutis 1999)
- Enlist school nurse
- Examine for nits/lice
- Remove nits (Licemeister comb, Step 2, Vinegar)
- Attention to fomites
|
|
29
|
- Repeat rx at 7-10 days
- Confirm nit free/fomite control
- Off-label agents for resistance
- Prevent resistance
- Rotate agents
- Remove nits
- Control fomites/contacts
- Multi-drug rx
|
|
30
|
|
|
31
|
|
|
32
|
|
|
33
|
|
|
34
|
|
|
35
|
- All ages, races, socioeconomic groups
- May be lower in Afro-Americans
- Endemic and “epidemic”
- Chronic infestation in poor countries
- Widespread in N America, Europe
|
|
36
|
|
|
37
|
|
|
38
|
- Sarcoptes scabiei var. humanis
- Class Arachnida
- Female .3 X .4 mm, secretes special substance
- Lays 3 eggs/day, hatch in 2-3 days, 3 nymph stages
- Female life span 4-6 wweeks, burrows @ .5-5 mm/day, lays up to 50 eggs
- Adult survives 24-36 hours off host
- Nymph survives 2-5 days off host
- Symptoms from host reaction
|
|
39
|
- Insidious onset
- Noctural pruritus
- Consistent cutaneous eruption
- Pleomorphic lesions
- Epidemiology
|
|
40
|
|
|
41
|
|
|
42
|
- Permethrin 5% cream
- Sulfur ointment 2-5%
- Lindane 1% lotion and cream
- Crotamiton 10% lotion and cream
|
|
43
|
- Class of compounds from Streptomyces
- avermitilis avermectins
- Avermectin B1 modified to ivermectin
- Macrocyclic lactone similar to macrolides
- Good antihelminthic-used for sarcoptic mange
- and heart worms in pets
- Approved in US for human onchocerciasis
|
|
44
|
- (Meinking, Taplin. The treatment
of scabies with ivermectin. N Eng
J Med 1995;333:26-30)
- 2 groups one comprised of normal hosts and a second with HIV were
treated with a single 200 ug/kg dose of ivermectin. Results suggest that this is a safe,
easy, effective Rx for scabies.
- Comment: There were failures
requiring reRx and combination Rx
|
|
45
|
- (Trujullo. Topical ivermectin: a
new successful Rx for scabies.
Pediatr Dermatol 2001;18:63-6)
- 6 complete families-12 adults, 20 1-10 yo
- 1% ivermectin solution in propylene glycol
- Applied twice in 1 week
- All cleared, no irritation
- Low cost effective Rx
|
|
46
|
- (Usha. A comparative study of
oral ivermectin and topical permethrin in the Rx of scabies. J Am Acad Dermatol
2000;42(2pt2):236-30)
- 85 pts randomized to 200ugm/kg ivermectin v overnight application of
permethrin
- F/U 1, 2, 4, 8 weeks
- Ivermectin 1 dose = 70% cure 2
doses = 95%
- Permethrin 1 dose = 97.8% cure
|
|
47
|
- Effective safe drug (but not as good as permethrin?)
- Useful in special circumstances (where hygiene
- is issue, pt incapacitated, no good support
- care)
- Two Rx of combination Rx probably necessary
|
|
48
|
|
|
49
|
- Use in treating head lice?
- Oral Rx may be effective
- Unreported open label S Am study shows that topical shampoo
effecive against crawlers and nits
- Our experience with cutaneous larva migrans
|
|
50
|
- Papular urticaria
- “Fleabitis”
- “Breakfast, lunch, and dinner
- Epidemiology-age, course
- Characteristic morphology of lesions
|
|
51
|
|
|
52
|
|
|
53
|
|
|
54
|
|
|
55
|
|